nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—ABCG2—Dactinomycin—uterine cancer	0.133	0.16	CbGbCtD
Rilpivirine—ABCG2—Carboplatin—uterine cancer	0.0894	0.107	CbGbCtD
Rilpivirine—ABCG2—Etoposide—uterine cancer	0.0751	0.0902	CbGbCtD
Rilpivirine—CYP2C19—Progesterone—uterine cancer	0.075	0.0901	CbGbCtD
Rilpivirine—CYP1A2—Progesterone—uterine cancer	0.0692	0.0831	CbGbCtD
Rilpivirine—ABCB1—Progesterone—uterine cancer	0.0605	0.0727	CbGbCtD
Rilpivirine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0547	0.0658	CbGbCtD
Rilpivirine—ABCG2—Doxorubicin—uterine cancer	0.0512	0.0615	CbGbCtD
Rilpivirine—ABCB1—Dactinomycin—uterine cancer	0.048	0.0577	CbGbCtD
Rilpivirine—CYP3A4—Progesterone—uterine cancer	0.0362	0.0436	CbGbCtD
Rilpivirine—CYP2B6—Doxorubicin—uterine cancer	0.036	0.0433	CbGbCtD
Rilpivirine—CYP1A2—Etoposide—uterine cancer	0.031	0.0372	CbGbCtD
Rilpivirine—ABCB1—Etoposide—uterine cancer	0.0271	0.0325	CbGbCtD
Rilpivirine—ABCB1—Doxorubicin—uterine cancer	0.0185	0.0222	CbGbCtD
Rilpivirine—CYP3A4—Etoposide—uterine cancer	0.0162	0.0195	CbGbCtD
Rilpivirine—CYP3A4—Doxorubicin—uterine cancer	0.0111	0.0133	CbGbCtD
Rilpivirine—Pazopanib—FGFR2—uterine cancer	0.00958	1	CrCbGaD
Rilpivirine—Nephrotic syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00467	0.0344	CcSEcCtD
Rilpivirine—Transaminases increased—Progesterone—uterine cancer	0.00409	0.0302	CcSEcCtD
Rilpivirine—Breast enlargement—Progesterone—uterine cancer	0.00384	0.0283	CcSEcCtD
Rilpivirine—Cholelithiasis—Medroxyprogesterone Acetate—uterine cancer	0.00363	0.0267	CcSEcCtD
Rilpivirine—Bilirubin total increased—Epirubicin—uterine cancer	0.00356	0.0262	CcSEcCtD
Rilpivirine—Bilirubin total increased—Doxorubicin—uterine cancer	0.00329	0.0243	CcSEcCtD
Rilpivirine—Nephrolithiasis—Medroxyprogesterone Acetate—uterine cancer	0.0028	0.0207	CcSEcCtD
Rilpivirine—Hepatotoxicity—Dactinomycin—uterine cancer	0.00228	0.0168	CcSEcCtD
Rilpivirine—Sleep disorder—Progesterone—uterine cancer	0.00209	0.0154	CcSEcCtD
Rilpivirine—Opportunistic infection—Epirubicin—uterine cancer	0.00177	0.0131	CcSEcCtD
Rilpivirine—Infection—Carboplatin—uterine cancer	0.00168	0.0124	CcSEcCtD
Rilpivirine—Hepatotoxicity—Etoposide—uterine cancer	0.00165	0.0122	CcSEcCtD
Rilpivirine—Opportunistic infection—Doxorubicin—uterine cancer	0.00164	0.0121	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Progesterone—uterine cancer	0.00163	0.012	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Progesterone—uterine cancer	0.00159	0.0117	CcSEcCtD
Rilpivirine—Blood creatinine increased—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.0113	CcSEcCtD
Rilpivirine—Abdominal discomfort—Progesterone—uterine cancer	0.0015	0.011	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.0106	CcSEcCtD
Rilpivirine—Depression—Progesterone—uterine cancer	0.00139	0.0102	CcSEcCtD
Rilpivirine—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.01	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Progesterone—uterine cancer	0.00132	0.00971	CcSEcCtD
Rilpivirine—Inflammation—Etoposide—uterine cancer	0.00131	0.00968	CcSEcCtD
Rilpivirine—Depression—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00927	CcSEcCtD
Rilpivirine—Urinary tract disorder—Progesterone—uterine cancer	0.00123	0.0091	CcSEcCtD
Rilpivirine—Urethral disorder—Progesterone—uterine cancer	0.00122	0.00903	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.0088	CcSEcCtD
Rilpivirine—Transaminases increased—Epirubicin—uterine cancer	0.00117	0.00865	CcSEcCtD
Rilpivirine—Serum creatinine increased—Epirubicin—uterine cancer	0.00116	0.00855	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.00115	0.00848	CcSEcCtD
Rilpivirine—Immune system disorder—Progesterone—uterine cancer	0.00113	0.00832	CcSEcCtD
Rilpivirine—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00825	CcSEcCtD
Rilpivirine—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00818	CcSEcCtD
Rilpivirine—Mental disorder—Progesterone—uterine cancer	0.00109	0.00807	CcSEcCtD
Rilpivirine—Malnutrition—Progesterone—uterine cancer	0.00109	0.00802	CcSEcCtD
Rilpivirine—Transaminases increased—Doxorubicin—uterine cancer	0.00109	0.008	CcSEcCtD
Rilpivirine—Serum creatinine increased—Doxorubicin—uterine cancer	0.00107	0.00791	CcSEcCtD
Rilpivirine—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00754	CcSEcCtD
Rilpivirine—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.000992	0.00732	CcSEcCtD
Rilpivirine—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.000986	0.00727	CcSEcCtD
Rilpivirine—Anxiety—Progesterone—uterine cancer	0.000923	0.00681	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00092	0.00678	CcSEcCtD
Rilpivirine—Dry mouth—Progesterone—uterine cancer	0.000906	0.00668	CcSEcCtD
Rilpivirine—Infection—Progesterone—uterine cancer	0.000882	0.0065	CcSEcCtD
Rilpivirine—Nervous system disorder—Progesterone—uterine cancer	0.000871	0.00642	CcSEcCtD
Rilpivirine—Skin disorder—Progesterone—uterine cancer	0.000862	0.00636	CcSEcCtD
Rilpivirine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000836	0.00617	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000833	0.00615	CcSEcCtD
Rilpivirine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000821	0.00605	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Etoposide—uterine cancer	0.000815	0.00601	CcSEcCtD
Rilpivirine—Insomnia—Progesterone—uterine cancer	0.000803	0.00592	CcSEcCtD
Rilpivirine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000799	0.00589	CcSEcCtD
Rilpivirine—Somnolence—Progesterone—uterine cancer	0.000789	0.00582	CcSEcCtD
Rilpivirine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000789	0.00582	CcSEcCtD
Rilpivirine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000781	0.00576	CcSEcCtD
Rilpivirine—Decreased appetite—Progesterone—uterine cancer	0.000772	0.00569	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Progesterone—uterine cancer	0.000766	0.00565	CcSEcCtD
Rilpivirine—Fatigue—Progesterone—uterine cancer	0.000765	0.00564	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Epirubicin—uterine cancer	0.000754	0.00556	CcSEcCtD
Rilpivirine—Creatinine increased—Epirubicin—uterine cancer	0.00075	0.00553	CcSEcCtD
Rilpivirine—Inflammation—Epirubicin—uterine cancer	0.000736	0.00542	CcSEcCtD
Rilpivirine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000728	0.00537	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Progesterone—uterine cancer	0.000726	0.00535	CcSEcCtD
Rilpivirine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000715	0.00527	CcSEcCtD
Rilpivirine—Abnormal dreams—Epirubicin—uterine cancer	0.000705	0.0052	CcSEcCtD
Rilpivirine—Abdominal pain—Progesterone—uterine cancer	0.000702	0.00518	CcSEcCtD
Rilpivirine—Renal failure—Etoposide—uterine cancer	0.0007	0.00516	CcSEcCtD
Rilpivirine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000699	0.00516	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Doxorubicin—uterine cancer	0.000698	0.00515	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000694	0.00512	CcSEcCtD
Rilpivirine—Creatinine increased—Doxorubicin—uterine cancer	0.000694	0.00511	CcSEcCtD
Rilpivirine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000694	0.00511	CcSEcCtD
Rilpivirine—Inflammation—Doxorubicin—uterine cancer	0.000681	0.00502	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Etoposide—uterine cancer	0.000673	0.00497	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000658	0.00485	CcSEcCtD
Rilpivirine—Abnormal dreams—Doxorubicin—uterine cancer	0.000652	0.00481	CcSEcCtD
Rilpivirine—Asthenia—Progesterone—uterine cancer	0.000637	0.0047	CcSEcCtD
Rilpivirine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000636	0.00469	CcSEcCtD
Rilpivirine—Urinary tract disorder—Etoposide—uterine cancer	0.000631	0.00465	CcSEcCtD
Rilpivirine—Urethral disorder—Etoposide—uterine cancer	0.000627	0.00462	CcSEcCtD
Rilpivirine—Infection—Dactinomycin—uterine cancer	0.000623	0.0046	CcSEcCtD
Rilpivirine—Diarrhoea—Progesterone—uterine cancer	0.000607	0.00448	CcSEcCtD
Rilpivirine—Dizziness—Progesterone—uterine cancer	0.000587	0.00433	CcSEcCtD
Rilpivirine—Immune system disorder—Etoposide—uterine cancer	0.000577	0.00426	CcSEcCtD
Rilpivirine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000577	0.00426	CcSEcCtD
Rilpivirine—Vomiting—Progesterone—uterine cancer	0.000564	0.00416	CcSEcCtD
Rilpivirine—Rash—Progesterone—uterine cancer	0.00056	0.00413	CcSEcCtD
Rilpivirine—Dermatitis—Progesterone—uterine cancer	0.000559	0.00412	CcSEcCtD
Rilpivirine—Headache—Progesterone—uterine cancer	0.000556	0.0041	CcSEcCtD
Rilpivirine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00055	0.00406	CcSEcCtD
Rilpivirine—Decreased appetite—Dactinomycin—uterine cancer	0.000545	0.00402	CcSEcCtD
Rilpivirine—Renal impairment—Epirubicin—uterine cancer	0.000544	0.00401	CcSEcCtD
Rilpivirine—Fatigue—Dactinomycin—uterine cancer	0.000541	0.00399	CcSEcCtD
Rilpivirine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000532	0.00392	CcSEcCtD
Rilpivirine—Nausea—Progesterone—uterine cancer	0.000527	0.00389	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000513	0.00378	CcSEcCtD
Rilpivirine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000511	0.00377	CcSEcCtD
Rilpivirine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000507	0.00374	CcSEcCtD
Rilpivirine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000507	0.00374	CcSEcCtD
Rilpivirine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000504	0.00372	CcSEcCtD
Rilpivirine—Renal impairment—Doxorubicin—uterine cancer	0.000504	0.00371	CcSEcCtD
Rilpivirine—Abdominal pain—Dactinomycin—uterine cancer	0.000496	0.00366	CcSEcCtD
Rilpivirine—Blood creatinine increased—Epirubicin—uterine cancer	0.000485	0.00358	CcSEcCtD
Rilpivirine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000478	0.00352	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00047	0.00347	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000466	0.00344	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000457	0.00337	CcSEcCtD
Rilpivirine—Infection—Etoposide—uterine cancer	0.000451	0.00333	CcSEcCtD
Rilpivirine—Asthenia—Dactinomycin—uterine cancer	0.00045	0.00332	CcSEcCtD
Rilpivirine—Blood creatinine increased—Doxorubicin—uterine cancer	0.000449	0.00331	CcSEcCtD
Rilpivirine—Skin disorder—Etoposide—uterine cancer	0.000441	0.00325	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000432	0.00318	CcSEcCtD
Rilpivirine—Diarrhoea—Dactinomycin—uterine cancer	0.000429	0.00317	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000423	0.00312	CcSEcCtD
Rilpivirine—Somnolence—Etoposide—uterine cancer	0.000404	0.00298	CcSEcCtD
Rilpivirine—Vomiting—Dactinomycin—uterine cancer	0.000399	0.00294	CcSEcCtD
Rilpivirine—Rash—Dactinomycin—uterine cancer	0.000396	0.00292	CcSEcCtD
Rilpivirine—Decreased appetite—Etoposide—uterine cancer	0.000395	0.00291	CcSEcCtD
Rilpivirine—Renal failure—Epirubicin—uterine cancer	0.000392	0.00289	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000392	0.00289	CcSEcCtD
Rilpivirine—Fatigue—Etoposide—uterine cancer	0.000392	0.00289	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Epirubicin—uterine cancer	0.000377	0.00278	CcSEcCtD
Rilpivirine—Nausea—Dactinomycin—uterine cancer	0.000373	0.00275	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Etoposide—uterine cancer	0.000371	0.00274	CcSEcCtD
Rilpivirine—Renal failure—Doxorubicin—uterine cancer	0.000363	0.00268	CcSEcCtD
Rilpivirine—Abdominal pain—Etoposide—uterine cancer	0.000359	0.00265	CcSEcCtD
Rilpivirine—Urinary tract disorder—Epirubicin—uterine cancer	0.000354	0.00261	CcSEcCtD
Rilpivirine—Urethral disorder—Epirubicin—uterine cancer	0.000351	0.00259	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000349	0.00258	CcSEcCtD
Rilpivirine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000327	0.00241	CcSEcCtD
Rilpivirine—Asthenia—Etoposide—uterine cancer	0.000326	0.0024	CcSEcCtD
Rilpivirine—Urethral disorder—Doxorubicin—uterine cancer	0.000325	0.0024	CcSEcCtD
Rilpivirine—Immune system disorder—Epirubicin—uterine cancer	0.000324	0.00239	CcSEcCtD
Rilpivirine—Mental disorder—Epirubicin—uterine cancer	0.000314	0.00231	CcSEcCtD
Rilpivirine—Malnutrition—Epirubicin—uterine cancer	0.000312	0.0023	CcSEcCtD
Rilpivirine—Diarrhoea—Etoposide—uterine cancer	0.000311	0.00229	CcSEcCtD
Rilpivirine—Dizziness—Etoposide—uterine cancer	0.0003	0.00221	CcSEcCtD
Rilpivirine—Immune system disorder—Doxorubicin—uterine cancer	0.000299	0.00221	CcSEcCtD
Rilpivirine—Mental disorder—Doxorubicin—uterine cancer	0.00029	0.00214	CcSEcCtD
Rilpivirine—Vomiting—Etoposide—uterine cancer	0.000289	0.00213	CcSEcCtD
Rilpivirine—Malnutrition—Doxorubicin—uterine cancer	0.000289	0.00213	CcSEcCtD
Rilpivirine—Rash—Etoposide—uterine cancer	0.000286	0.00211	CcSEcCtD
Rilpivirine—Dermatitis—Etoposide—uterine cancer	0.000286	0.00211	CcSEcCtD
Rilpivirine—Headache—Etoposide—uterine cancer	0.000284	0.0021	CcSEcCtD
Rilpivirine—Nausea—Etoposide—uterine cancer	0.00027	0.00199	CcSEcCtD
Rilpivirine—Anxiety—Epirubicin—uterine cancer	0.000265	0.00195	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000264	0.00194	CcSEcCtD
Rilpivirine—Dry mouth—Epirubicin—uterine cancer	0.00026	0.00192	CcSEcCtD
Rilpivirine—Infection—Epirubicin—uterine cancer	0.000253	0.00186	CcSEcCtD
Rilpivirine—Nervous system disorder—Epirubicin—uterine cancer	0.00025	0.00184	CcSEcCtD
Rilpivirine—Skin disorder—Epirubicin—uterine cancer	0.000247	0.00182	CcSEcCtD
Rilpivirine—Anxiety—Doxorubicin—uterine cancer	0.000245	0.00181	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000244	0.0018	CcSEcCtD
Rilpivirine—Dry mouth—Doxorubicin—uterine cancer	0.00024	0.00177	CcSEcCtD
Rilpivirine—Infection—Doxorubicin—uterine cancer	0.000234	0.00173	CcSEcCtD
Rilpivirine—Nervous system disorder—Doxorubicin—uterine cancer	0.000231	0.0017	CcSEcCtD
Rilpivirine—Insomnia—Epirubicin—uterine cancer	0.00023	0.0017	CcSEcCtD
Rilpivirine—Skin disorder—Doxorubicin—uterine cancer	0.000229	0.00169	CcSEcCtD
Rilpivirine—Somnolence—Epirubicin—uterine cancer	0.000226	0.00167	CcSEcCtD
Rilpivirine—Decreased appetite—Epirubicin—uterine cancer	0.000221	0.00163	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00022	0.00162	CcSEcCtD
Rilpivirine—Fatigue—Epirubicin—uterine cancer	0.000219	0.00162	CcSEcCtD
Rilpivirine—Insomnia—Doxorubicin—uterine cancer	0.000213	0.00157	CcSEcCtD
Rilpivirine—Somnolence—Doxorubicin—uterine cancer	0.000209	0.00154	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000208	0.00154	CcSEcCtD
Rilpivirine—Decreased appetite—Doxorubicin—uterine cancer	0.000205	0.00151	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000203	0.0015	CcSEcCtD
Rilpivirine—Fatigue—Doxorubicin—uterine cancer	0.000203	0.0015	CcSEcCtD
Rilpivirine—Abdominal pain—Epirubicin—uterine cancer	0.000201	0.00148	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000193	0.00142	CcSEcCtD
Rilpivirine—Abdominal pain—Doxorubicin—uterine cancer	0.000186	0.00137	CcSEcCtD
Rilpivirine—Asthenia—Epirubicin—uterine cancer	0.000183	0.00135	CcSEcCtD
Rilpivirine—Diarrhoea—Epirubicin—uterine cancer	0.000174	0.00128	CcSEcCtD
Rilpivirine—Asthenia—Doxorubicin—uterine cancer	0.000169	0.00125	CcSEcCtD
Rilpivirine—Dizziness—Epirubicin—uterine cancer	0.000168	0.00124	CcSEcCtD
Rilpivirine—Vomiting—Epirubicin—uterine cancer	0.000162	0.00119	CcSEcCtD
Rilpivirine—Diarrhoea—Doxorubicin—uterine cancer	0.000161	0.00119	CcSEcCtD
Rilpivirine—Rash—Epirubicin—uterine cancer	0.00016	0.00118	CcSEcCtD
Rilpivirine—Dermatitis—Epirubicin—uterine cancer	0.00016	0.00118	CcSEcCtD
Rilpivirine—Headache—Epirubicin—uterine cancer	0.000159	0.00118	CcSEcCtD
Rilpivirine—Dizziness—Doxorubicin—uterine cancer	0.000156	0.00115	CcSEcCtD
Rilpivirine—Nausea—Epirubicin—uterine cancer	0.000151	0.00112	CcSEcCtD
Rilpivirine—Vomiting—Doxorubicin—uterine cancer	0.00015	0.0011	CcSEcCtD
Rilpivirine—Rash—Doxorubicin—uterine cancer	0.000149	0.0011	CcSEcCtD
Rilpivirine—Dermatitis—Doxorubicin—uterine cancer	0.000148	0.00109	CcSEcCtD
Rilpivirine—Headache—Doxorubicin—uterine cancer	0.000148	0.00109	CcSEcCtD
Rilpivirine—Nausea—Doxorubicin—uterine cancer	0.00014	0.00103	CcSEcCtD
Rilpivirine—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	8.34e-05	0.00367	CbGpPWpGaD
Rilpivirine—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	8.25e-05	0.00363	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	8.21e-05	0.00362	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	8.12e-05	0.00358	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	8.12e-05	0.00358	CbGpPWpGaD
Rilpivirine—CYP2B6—Metapathway biotransformation—AKR1C3—uterine cancer	8e-05	0.00352	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	7.94e-05	0.0035	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	7.85e-05	0.00346	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—ABCC9—uterine cancer	7.72e-05	0.0034	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—ESR1—uterine cancer	7.58e-05	0.00334	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—SRD5A2—uterine cancer	7.45e-05	0.00328	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—NDUFB11—uterine cancer	7.45e-05	0.00328	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—EP300—uterine cancer	7.4e-05	0.00326	CbGpPWpGaD
Rilpivirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	7.35e-05	0.00324	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.23e-05	0.00319	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—ABCC9—uterine cancer	7.15e-05	0.00315	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	7.14e-05	0.00314	CbGpPWpGaD
Rilpivirine—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	7.01e-05	0.00309	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	7.01e-05	0.00309	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	6.92e-05	0.00305	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	6.9e-05	0.00304	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.83e-05	0.00301	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—PGR—uterine cancer	6.83e-05	0.00301	CbGpPWpGaD
Rilpivirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	6.67e-05	0.00294	CbGpPWpGaD
Rilpivirine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	6.58e-05	0.0029	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	6.49e-05	0.00286	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—EZH2—uterine cancer	6.49e-05	0.00286	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	6.43e-05	0.00283	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	6.4e-05	0.00282	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—CYP19A1—uterine cancer	6.32e-05	0.00278	CbGpPWpGaD
Rilpivirine—CYP2B6—Metapathway biotransformation—CYP19A1—uterine cancer	6.23e-05	0.00275	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	6.12e-05	0.0027	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	6.05e-05	0.00266	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—ESR2—uterine cancer	6.01e-05	0.00265	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.96e-05	0.00263	CbGpPWpGaD
Rilpivirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	5.78e-05	0.00255	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.76e-05	0.00254	CbGpPWpGaD
Rilpivirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	5.41e-05	0.00238	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—STAR—uterine cancer	5.38e-05	0.00237	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—AKR1B1—uterine cancer	5.38e-05	0.00237	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	5.37e-05	0.00237	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.32e-05	0.00234	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	5.09e-05	0.00224	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	5.06e-05	0.00223	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—NDUFB11—uterine cancer	5e-05	0.0022	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—SRD5A2—uterine cancer	5e-05	0.0022	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	4.99e-05	0.0022	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—CDKN2B—uterine cancer	4.9e-05	0.00216	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.86e-05	0.00214	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	4.85e-05	0.00214	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	4.85e-05	0.00214	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	4.78e-05	0.0021	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	4.72e-05	0.00208	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	4.72e-05	0.00208	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	4.71e-05	0.00207	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	4.71e-05	0.00207	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—SRD5A2—uterine cancer	4.63e-05	0.00204	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—NDUFB11—uterine cancer	4.63e-05	0.00204	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.59e-05	0.00202	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.49e-05	0.00198	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	4.47e-05	0.00197	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—SMAD3—uterine cancer	4.47e-05	0.00197	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	4.29e-05	0.00189	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	4.26e-05	0.00188	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	4.26e-05	0.00188	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—POLD1—uterine cancer	4.22e-05	0.00186	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.17e-05	0.00183	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.17e-05	0.00183	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	4.15e-05	0.00183	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CXCL8—uterine cancer	4.04e-05	0.00178	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	4.04e-05	0.00178	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	4e-05	0.00176	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	3.99e-05	0.00176	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—AKR1C1—uterine cancer	3.95e-05	0.00174	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	3.9e-05	0.00172	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.87e-05	0.0017	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	3.85e-05	0.0017	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	3.84e-05	0.00169	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	3.79e-05	0.00167	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	3.72e-05	0.00164	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	3.67e-05	0.00162	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—ESR1—uterine cancer	3.65e-05	0.00161	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	3.64e-05	0.0016	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—AKR1B1—uterine cancer	3.62e-05	0.00159	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—STAR—uterine cancer	3.62e-05	0.00159	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.58e-05	0.00157	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—RRM2—uterine cancer	3.52e-05	0.00155	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	3.43e-05	0.00151	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—DCN—uterine cancer	3.42e-05	0.00151	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—SRD5A2—uterine cancer	3.4e-05	0.0015	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NDUFB11—uterine cancer	3.4e-05	0.0015	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—AKR1B1—uterine cancer	3.35e-05	0.00148	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—STAR—uterine cancer	3.35e-05	0.00148	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—VEGFA—uterine cancer	3.28e-05	0.00144	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.25e-05	0.00143	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.25e-05	0.00143	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CYP11A1—uterine cancer	3.22e-05	0.00142	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.06e-05	0.00135	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—AKR1C3—uterine cancer	3.04e-05	0.00134	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.92e-05	0.00128	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.87e-05	0.00126	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.86e-05	0.00126	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—POLD1—uterine cancer	2.84e-05	0.00125	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.83e-05	0.00125	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—AKR1C1—uterine cancer	2.66e-05	0.00117	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—POLD1—uterine cancer	2.63e-05	0.00116	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NDUFB11—uterine cancer	2.57e-05	0.00113	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SRD5A2—uterine cancer	2.57e-05	0.00113	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NDUFB11—uterine cancer	2.5e-05	0.0011	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SRD5A2—uterine cancer	2.5e-05	0.0011	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.49e-05	0.0011	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—AKR1C1—uterine cancer	2.46e-05	0.00108	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—AKR1B1—uterine cancer	2.46e-05	0.00108	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—STAR—uterine cancer	2.46e-05	0.00108	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	2.42e-05	0.00106	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.38e-05	0.00105	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CYP19A1—uterine cancer	2.37e-05	0.00104	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—STK11—uterine cancer	2.37e-05	0.00104	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—RRM2—uterine cancer	2.37e-05	0.00104	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.35e-05	0.00104	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—DCN—uterine cancer	2.3e-05	0.00101	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.22e-05	0.00098	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—RRM2—uterine cancer	2.19e-05	0.000965	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CYP11A1—uterine cancer	2.16e-05	0.000953	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—DCN—uterine cancer	2.13e-05	0.000937	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.12e-05	0.000935	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.1e-05	0.000926	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—AKR1C3—uterine cancer	2.04e-05	0.0009	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CYP11A1—uterine cancer	2e-05	0.000883	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NDUFB11—uterine cancer	2e-05	0.000881	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SRD5A2—uterine cancer	2e-05	0.000881	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.95e-05	0.000857	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.94e-05	0.000855	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—POLD1—uterine cancer	1.93e-05	0.000849	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—AKR1C3—uterine cancer	1.89e-05	0.000834	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.86e-05	0.000817	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—STAR—uterine cancer	1.86e-05	0.000817	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.84e-05	0.00081	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.83e-05	0.000808	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.83e-05	0.000808	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—AKR1B1—uterine cancer	1.81e-05	0.000798	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—STAR—uterine cancer	1.81e-05	0.000798	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—AKR1C1—uterine cancer	1.8e-05	0.000794	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.79e-05	0.000789	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—MTHFR—uterine cancer	1.78e-05	0.000784	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.71e-05	0.000753	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.62e-05	0.000713	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—RRM2—uterine cancer	1.61e-05	0.000707	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CYP19A1—uterine cancer	1.59e-05	0.000701	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—STK11—uterine cancer	1.59e-05	0.000701	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.57e-05	0.000691	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—DCN—uterine cancer	1.56e-05	0.000687	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.54e-05	0.00068	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.54e-05	0.00068	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.49e-05	0.000658	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—STK11—uterine cancer	1.47e-05	0.000649	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CYP19A1—uterine cancer	1.47e-05	0.000649	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.47e-05	0.000647	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—POLD1—uterine cancer	1.46e-05	0.000641	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—STAR—uterine cancer	1.45e-05	0.000637	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.45e-05	0.000637	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.43e-05	0.000629	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.43e-05	0.000628	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—POLD1—uterine cancer	1.42e-05	0.000626	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—AKR1C3—uterine cancer	1.39e-05	0.000611	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.38e-05	0.000606	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.36e-05	0.0006	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—AKR1C1—uterine cancer	1.33e-05	0.000585	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—AKT1—uterine cancer	1.32e-05	0.000579	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.26e-05	0.000557	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.22e-05	0.000539	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—RRM2—uterine cancer	1.21e-05	0.000535	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—MTHFR—uterine cancer	1.2e-05	0.000527	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—RRM2—uterine cancer	1.18e-05	0.000522	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—DCN—uterine cancer	1.18e-05	0.000519	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—DCN—uterine cancer	1.15e-05	0.000507	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—POLD1—uterine cancer	1.13e-05	0.0005	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—STAR—uterine cancer	1.12e-05	0.000491	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.12e-05	0.000491	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.11e-05	0.000489	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—MTHFR—uterine cancer	1.11e-05	0.000488	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP11A1—uterine cancer	1.08e-05	0.000477	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—STK11—uterine cancer	1.08e-05	0.000476	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYP19A1—uterine cancer	1.08e-05	0.000476	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.06e-05	0.000467	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.05e-05	0.000464	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.05e-05	0.000462	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.03e-05	0.000455	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—AKR1C3—uterine cancer	1.02e-05	0.000451	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTEN—uterine cancer	9.91e-06	0.000436	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—RRM2—uterine cancer	9.46e-06	0.000417	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—EP300—uterine cancer	9.45e-06	0.000416	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—DCN—uterine cancer	9.18e-06	0.000404	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—POLD1—uterine cancer	8.75e-06	0.000386	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP11A1—uterine cancer	8.65e-06	0.000381	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AKR1C1—uterine cancer	8.19e-06	0.000361	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AKR1C3—uterine cancer	8.17e-06	0.00036	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—STK11—uterine cancer	8.17e-06	0.00036	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP19A1—uterine cancer	8.17e-06	0.00036	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—MTHFR—uterine cancer	8.12e-06	0.000358	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—STK11—uterine cancer	7.97e-06	0.000351	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP19A1—uterine cancer	7.97e-06	0.000351	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.67e-06	0.000338	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.31e-06	0.000322	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—RRM2—uterine cancer	7.3e-06	0.000321	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—DCN—uterine cancer	7.09e-06	0.000312	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CA—uterine cancer	6.99e-06	0.000308	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP11A1—uterine cancer	6.68e-06	0.000294	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTEN—uterine cancer	6.66e-06	0.000293	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP19A1—uterine cancer	6.36e-06	0.00028	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—STK11—uterine cancer	6.36e-06	0.00028	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—EP300—uterine cancer	6.35e-06	0.00028	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AKR1C3—uterine cancer	6.3e-06	0.000278	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTEN—uterine cancer	6.16e-06	0.000271	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—MTHFR—uterine cancer	6.14e-06	0.00027	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—MTHFR—uterine cancer	5.99e-06	0.000264	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.97e-06	0.000263	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—EP300—uterine cancer	5.88e-06	0.000259	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—AKT1—uterine cancer	5.71e-06	0.000252	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.7e-06	0.000251	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.41e-06	0.000238	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—STK11—uterine cancer	4.91e-06	0.000216	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.91e-06	0.000216	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—MTHFR—uterine cancer	4.78e-06	0.000211	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CA—uterine cancer	4.7e-06	0.000207	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTEN—uterine cancer	4.52e-06	0.000199	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CA—uterine cancer	4.35e-06	0.000192	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—EP300—uterine cancer	4.31e-06	0.00019	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.21e-06	0.000186	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—AKT1—uterine cancer	3.84e-06	0.000169	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—MTHFR—uterine cancer	3.69e-06	0.000163	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—AKT1—uterine cancer	3.55e-06	0.000156	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTEN—uterine cancer	3.41e-06	0.00015	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTEN—uterine cancer	3.33e-06	0.000147	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—EP300—uterine cancer	3.26e-06	0.000143	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CA—uterine cancer	3.19e-06	0.00014	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—EP300—uterine cancer	3.18e-06	0.00014	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTEN—uterine cancer	2.66e-06	0.000117	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—AKT1—uterine cancer	2.6e-06	0.000115	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—EP300—uterine cancer	2.54e-06	0.000112	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.41e-06	0.000106	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CA—uterine cancer	2.35e-06	0.000104	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTEN—uterine cancer	2.05e-06	9.04e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—AKT1—uterine cancer	1.97e-06	8.67e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—EP300—uterine cancer	1.96e-06	8.62e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—AKT1—uterine cancer	1.92e-06	8.46e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.88e-06	8.27e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AKT1—uterine cancer	1.53e-06	6.75e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.45e-06	6.38e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AKT1—uterine cancer	1.18e-06	5.21e-05	CbGpPWpGaD
